Association between high-normal levels of alanine aminotransferase and risk factors for atherogenesis
- PMID: 23973920
- PMCID: PMC3840068
- DOI: 10.1053/j.gastro.2013.08.036
Association between high-normal levels of alanine aminotransferase and risk factors for atherogenesis
Abstract
Background & aims: Liver disease has been associated with cardiovascular disorders, but little is known about the relationship between serum levels of alanine aminotransferase (ALT) and markers of atherogenesis. We investigated the relationship between low-normal and high-normal levels of ALT and an extended panel of cardiovascular risk factors among individuals with no known diseases in a primary care setting.
Methods: We performed a retrospective analysis of data collected from 6442 asymptomatic patients at wellness visits to a primary care setting in central Virginia from 2010 through 2011. Serum levels of ALT were compared with levels of lipids and lipoproteins, as well as metabolic, inflammatory, and coagulation-related factors associated with risk for cardiovascular disease.
Results: Serum levels of ALT were higher than 40 IU/L in 12% of subjects, and in the high-normal range (19-40 IU/L in women and 31-40 IU/L in men) in 25% of subjects. ALT level was associated with the apolipoprotein B level, concentration and particle size of very-low-density lipoproteins, concentration of low-density lipoprotein (LDL) particles (LDL-P), and percentages of small dense LDL (sdLDL) and sdLDL-cholesterol (sdLDL-C) (P < .0001 for all). A high-normal level of ALT was associated with higher levels of LDL-C, LDL-P, sdLDL-C, and sdLDL particles (P < .001 for all). These effects were independent of age, body mass index, and hyperinsulinemia. Increasing levels of ALT and fasting hyperinsulinemia (>12 μU/mL) synergized with increasing levels of triglycerides, very-low-density lipoprotein particles, LDL-P, sdLDL-C, and percentage of sdLDL-C. Levels of APOA1, high-density lipoprotein-cholesterol, and high-density lipoprotein-class 2 were associated inversely with serum level of ALT (P < .0001 for all).
Conclusions: In an analysis of asymptomatic individuals, increased serum levels of ALT (even high-normal levels) are associated with markers of cardiovascular disease.
Keywords: ALT; Atherosclerosis; BMI; HDL; HDL(INC); HDL-C; HDL2-C; Health Diagnostic Laboratories; Heart Disease; LDL; LDL-C; LDL-P; NAFLD; NASH; TSH; VLDL; VLDL-P; alanine aminotransferase; apoA; apoB; apolipoprotein A; apolipoprotein B; body mass index; high-density lipoprotein; high-density lipoprotein cholesterol; high-density lipoprotein subclass II cholesterol; low-density lipoprotein; low-density lipoprotein cholesterol; low-density lipoprotein particles; nonalcoholic fatty liver disease; sdLDL; small dense low-density lipoprotein; thyroid-stimulating hormone; very-low-density lipoprotein; very-low-density lipoprotein particle.
Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3840068/bin/nihms517900f1a.gif)
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3840068/bin/nihms517900f1a.gif)
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3840068/bin/nihms517900f1a.gif)
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3840068/bin/nihms517900f1a.gif)
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3840068/bin/nihms517900f1a.gif)
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3840068/bin/nihms517900f1a.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3840068/bin/nihms517900f2a.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3840068/bin/nihms517900f2a.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3840068/bin/nihms517900f2a.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3840068/bin/nihms517900f2a.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3840068/bin/nihms517900f2a.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3840068/bin/nihms517900f2a.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3840068/bin/nihms517900f3.gif)
Comment in
-
An ALTer ego of serum ALT: is it more than a marker of liver inflammation?Gastroenterology. 2013 Dec;145(6):1191-3. doi: 10.1053/j.gastro.2013.10.040. Epub 2013 Oct 28. Gastroenterology. 2013. PMID: 24176872 No abstract available.
-
Reply: To PMID 23973920.Gastroenterology. 2014 May;146(5):1427-8. doi: 10.1053/j.gastro.2014.03.043. Epub 2014 Mar 26. Gastroenterology. 2014. PMID: 24681172 No abstract available.
-
Liver and atherosclerosis.Gastroenterology. 2014 May;146(5):1427. doi: 10.1053/j.gastro.2014.01.068. Epub 2014 Mar 26. Gastroenterology. 2014. PMID: 24681174 No abstract available.
Similar articles
-
[Small-Dense LDL, HDL2, 3].Rinsho Byori. 2016 Jun;64(6):636-642. Rinsho Byori. 2016. PMID: 30695317 Review. Japanese.
-
De novo hepatic steatosis drives atherogenic risk in liver transplantation recipients.Liver Transpl. 2015 Nov;21(11):1395-402. doi: 10.1002/lt.24223. Liver Transpl. 2015. PMID: 26228654
-
Evolution of serum atherogenic risk in liver transplant recipients: Role of lipoproteins and metabolic and inflammatory markers.Liver Transpl. 2015 May;21(5):623-30. doi: 10.1002/lt.24100. Epub 2015 Apr 15. Liver Transpl. 2015. PMID: 25762084
-
The association of alanine aminotransferase within the normal and mildly elevated range with lipoproteins and apolipoproteins: the Insulin Resistance Atherosclerosis Study.Diabetologia. 2013 Apr;56(4):746-57. doi: 10.1007/s00125-012-2826-4. Epub 2013 Jan 24. Diabetologia. 2013. PMID: 23344727 Free PMC article.
-
Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity.Am J Cardiol. 2002 Oct 17;90(8A):30i-47i. doi: 10.1016/s0002-9149(02)02749-2. Am J Cardiol. 2002. PMID: 12419479 Review.
Cited by
-
Higher serum alanine aminotransferase levels and the incidence of hypertension: The Kailuan cohort study.Am J Prev Cardiol. 2024 Mar 3;17:100644. doi: 10.1016/j.ajpc.2024.100644. eCollection 2024 Mar. Am J Prev Cardiol. 2024. PMID: 38586187 Free PMC article.
-
The newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease.Front Endocrinol (Lausanne). 2023 Aug 31;14:1239398. doi: 10.3389/fendo.2023.1239398. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37727457 Free PMC article.
-
Phenome-Wide Association Analysis Reveals Novel Links Between Genetically Determined Levels of Liver Enzymes and Disease Phenotypes.Phenomics. 2022 Jan 11;2(5):295-311. doi: 10.1007/s43657-021-00033-y. eCollection 2022 Oct. Phenomics. 2022. PMID: 36939802 Free PMC article.
-
Changes in liver enzymes are associated with changes in insulin resistance, inflammatory biomarkers and leptin in prepubertal children with obesity.Ital J Pediatr. 2023 Mar 9;49(1):29. doi: 10.1186/s13052-023-01434-7. Ital J Pediatr. 2023. PMID: 36894963 Free PMC article.
-
Causal effects of genetically predicted type 2 diabetes mellitus on blood lipid profiles and concentration of particle-size-determined lipoprotein subclasses: A two-sample Mendelian randomization study.Front Cardiovasc Med. 2022 Oct 13;9:965995. doi: 10.3389/fcvm.2022.965995. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36312274 Free PMC article.
References
-
- Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol. 2003;98(5):960–967. - PubMed
-
- Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, et al. Prevalence of hepatic steatosis in an urban population in the united states: Impact of ethnicity. Hepatology. 2004;40(6):1387–1395. - PubMed
-
- Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, Landt CL, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: A prospective study. Gastroenterology. 2010;140:124–131. - PubMed
-
- Vernon G, Baranova A, Younossi ZM. Systematic review: The epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34(3):274–285. - PubMed
-
- Prati D, Taioli E, Zanella A, Della Torre E, Butelli S, Del Vecchio E, Vianello L, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med. 2002;137(1):1–10. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous